Summit Therapeutics ROA - Return on Assets 2015-2024 | SMMT

Summit Therapeutics return on assets for the quarter ending June 30, 2024 was -68.51.

  • Summit Therapeutics average return on assets for 2023 was -207.55, a 232.29% decline from 2022.
  • Summit Therapeutics average return on assets for 2022 was -62.46, a 9.24% increase from 2021.
  • Summit Therapeutics average return on assets for 2021 was -68.82, a 1.43% decline from 2020.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.

Summit Therapeutics ROA - Return on Assets 2015-2024 | SMMT

  • Summit Therapeutics average return on assets for 2023 was -207.55, a 232.29% decline from 2022.
  • Summit Therapeutics average return on assets for 2022 was -62.46, a 9.24% increase from 2021.
  • Summit Therapeutics average return on assets for 2021 was -68.82, a 1.43% decline from 2020.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.